期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 59, 期 7, 页码 3409-3417出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.jmedchem.6b00043
关键词
-
资金
- Staatsministerium fur Kunst and Wissenschaft (SMWK)
- European Union
- Free State of Saxony (ESF)
- Graduate School Leipzig School of Natural Sciencesec-Building with Molecules and Nano-objects (BuildMoNa)
Bioconjugates containing the neuropeptide Y (NPY) analogue [F-7,P-34]-NPY as targeting moiety are able to deliver toxic agents specifically to breast cancer cells that overexpress the human Y-1-receptor (hY(1)R). To increase their activity, multiple toxophores can be attached to one peptide. Herein, synthesis and characterization of [F-7,P-34]-NPY conjugates containing two methotrexate (MTX) molecules are presented. First, carboxytetramethylrhodamine was linked to [F-7,P-34]-NPY by amide or enzymatic linkage. The conjugate containing the enzymatic cleavage site showed high extracellular stability and fast intracellular release. Then, MTX was introduced at positions four and 22 of [F-7,P-34]-NPY, connected by enzymatic or amide linkage. The toxicity of the analogues on breast cancer cells was hY(1)R-mediated and dependent on the used linkage and amount of toxophores. Furthermore, conjugates revealed higher potency than MTX on MTX-resistant cells. These results emphasize that peptide-drug conjugates can overcome drug resistance and that the attachment of multiple cleavable toxophores enhances the efficiency of this smart delivery system.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据